Our work establishes succinylation as a master regulator of splicing-mediated DDR in HCC while nominating the KAT2A-SRSF11-RAD52 circuit as a therapeutic target to overcome radioresistance. This evidence concerns the gene RAD52 and hepatocellular carcinoma.